Modern principles in the management of nodular lymphocyte-predominant Hodgkin lymphoma
Author:
Affiliation:
1. Division of Oncology; Department of Medicine; Stanford University; Stanford CA USA
2. Department of Medicine; New York-Presbyterian Hospital/Weill Cornell Medicine; New York NY USA
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15616/fullpdf
Reference61 articles.
1. How I treat nodular lymphocyte predominant Hodgkin lymphoma;Advani;Blood,2013
2. Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma;Advani;Journal of Clinical Oncology,2014
3. High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: a retrospective study by the European society for blood and marrow transplantation-lymphoma working party;Akhtar;American Journal of Hematology,2018
4. Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin's lymphoma;Al-Mansour;Journal of Clinical Oncology,2010
5. Adult nodular lymphocyte-predominant Hodgkin lymphoma: treatment modality utilization and survival;Alonso;Cancer Medicine,2018
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Intra‐tumoral and peripheral blood TIGIT and PD‐1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma;American Journal of Hematology;2024-08-17
2. Diffuse Variant of Nodular Lymphocyte-Predominant Hodgkin Lymphoma in A 39-Year-Old Female: A Rare Case Report from Syria;Steps Journal for Pathology and Laboratory Medicine;2023
3. EBV-positive nodular lymphocyte predominant Hodgkin lymphoma: a single institution experience;Human Pathology;2022-11
4. Proposal of ‘reactive‐lymphocyte/histiocyte rich large B‐cell lymphoma’ as an alternate term for ‘nodular lymphocyte predominant Hodgkin lymphoma’ that would also address its overlap with T‐cell/histiocyte rich large B‐cell lymphoma;eJHaem;2022-08-31
5. Utility of pre-treatment FDG PET/CT–derived machine learning models for outcome prediction in classical Hodgkin lymphoma;European Radiology;2022-08-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3